This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypert…

Pulmonary HypertensionInterstitial Lung Disease (ILD)Lung Diseases+3 more

~Estimated

~$10 – $8,750

Pulmovant, Inc.NCT07333183

Observational

MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with intersti…

Pulmonary HypertensionInterstitial Lung Disease (ILD)

~Estimated

~$10 – $7,500

Tempus AINCT06911632